RecallRadar

FDA Device recall Z-0303-2019

Brilliance Big Bore Oncology CT (Model No. 728243) software version 4.2.0 Product Usage: Computed Tomography X-ray systems intended to prod…

On 2018-11-07 the FDA classified a Class II recall of Brilliance Big Bore Oncology CT (Model No. 728243) software version 4.2.0 Product Usage: Computed Tomography X-ray systems intended to prod… by Philips Medical Systems Cleveland, citing it was reported that scanners running certain software versions provide confusing information in the "Impressions" section of the Calcium Score report. The generated report provid….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0303-2019
ClassificationClass II
Statusterminated
Initiated2017-06-07
Published2018-11-07
Last updated2026-09-13 11:54 UTC
CompanyPhilips Medical Systems Cleveland
DistributionUS

Product

Brilliance Big Bore Oncology CT (Model No. 728243) software version 4.2.0 Product Usage: Computed Tomography X-ray systems intended to produce cross-sectional Images of the body by computer reconstruction of X-ray transmission data taken at different angles and planes. These devices may include signal analysts and display equipment, patient and equipment supports, components, and accessories.

Reason

It was reported that scanners running certain software versions provide confusing information in the "Impressions" section of the Calcium Score report. The generated report provides multiple analyses of the amount of plaque detected, as if they all apply to the patient at the same time. This misleading guidance can be potentially misleading to the user, and may lead to mistreatment of the patient.

Identifiers

code_infoSoftware version 4.2.0

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:54 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0303-2019%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.